Future therapies involve use of factor X inhibitors or direct thrombin inhibitors. The data is currently not mature enough to make any clinical recommendations.
Heparin-induced thrombocytopenia future or investigational therapies
Glanzmann's thrombasthenia medical therapy
Glanzmann's thrombasthenia future or investigational therapies
Heparin-induced thrombocytopenia primary prevention
Heparin-induced thrombocytopenia medical therapy
Thrombotic thrombocytopenic purpura medical therapy
Thrombotic thrombocytopenic purpura secondary prevention
Antiphospholipid syndrome primary prevention